Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 18 results for "pfizer drugmaker pfizer"

As AstraZeneca chases rivals, immuno-oncology gets complicated
Reuters

As AstraZeneca chases rivals, immuno-oncology gets complicated

Three years after Pfizer's failed bid for AstraZeneca, the British drugmaker aims to prove in the coming weeks that its cancer immunotherapy can deliver on bold sales forecasts made during that takeover battle. Central to AstraZeneca's case is a trial called ... Reuters, 2 months ago

30 images for pfizer drugmaker pfizer

First Post.com, 2 months ago
Investor's Business Daily, 4 months ago
Malay Mail, 5 months ago
Mail.com, 4 months ago
Dotemirates.com, 6 months ago
Motley Fool, 5 months ago
Yahoo! Finance, 5 months ago
CaribbeanBusiness.com, 7 months ago
San Francisco Chronicle.com, 8 months ago
Research & Development, 6 months ago

Pfizer denies over-charging for cancer drugs in South Africa

U. S. drugmaker Pfizer has denied allegations it over-charged for cancer medicines in South Africa following an investigation launched on Tuesday into three drug companies by the country's competition watchdog.
 DNA1 week ago
Reuters

Pfizer strikes deal with Sangamo, broadening hemophilia pipeline

NEW YORK (Reuters) - U.S. drugmaker Pfizer Inc said on Wednesday it reached an agreement with Sangamo Therapeutics Inc for rights to its gene therapy programs to treat the rare blood-clotting disorder hemophilia A, under which Pfizer will pay $70 million ...
 Reuters1 month ago
Sify

US STOCKS-Wall St flat as Fed meet kicks off; Nasdaq hits record

* Coach, MasterCard rise after results best estimates * Apple hits record ahead of quarterly results * Pfizer down after revenue misses estimates * Dow up 0.03 pct, S&P down 0.06 pct, Nasdaq down 0.11 pct(Updates to open) By Tanya Agrawal May 2 (Reuters) - ...
 Sify1 month ago US STOCKS-Wall St flat as Apple-led tech gains offset weak consumer stocks  Sify1 month ago US STOCKS-Wall St modestly higher as Apple leads tech stocks' gains  Sify1 month ago US STOCKS-Wall St set to open flat; Fed meet, Apple report awaited  Sify1 month ago
Reuters

Pfizer subpoenaed in U.S. intravenous saline solution probe

Pfizer Inc has received grand jury subpoenas from the U.S. Justice Department in connection with an antitrust investigation focusing on drugmakers that market intravenous saline solutions. The drugmaker disclosed the subpoenas in a statement on Wednesday ...
 Reuters2 months ago
Reuters

Roche's Alecensa notches trial win against Pfizer's Xalkori

ZURICH (Reuters) - Roche's Alecensa kept people with a specific lung cancer alive longer without their disease progressing than Pfizer's Xalkori, the Swiss drugmaker said on Monday, as it seeks to move in on the U.S. company's share of early treatment of the ...
 Reuters2 months ago

Novartis breast cancer drug Kisqali wins European panel backing

A European Medicines Agency (EMA) panel recommended on Friday approving Novartis's Kisqali drug, bolstering the Swiss drugmaker's bid to challenge rival Pfizer's Ibrance against tough-to-treat breast cancer. The EMA's Committee for Medicinal Products for ...
 Reuters4 days ago

EU tests limits of drug pricing freedom in landmark probe

By Foo Yun Chee and Ben Hirschler BRUSSELS/LONDON (Reuters) - The first ever EU antitrust probe into excessive drug pricing is taking the European pharmaceuticals industry into uncharted territory, unnerving some companies and lawyers worried about the reach ...
 Sify1 day ago
Sify

Drug approvals bounce back as R&D labs churn out new winners

By Ben Hirschler LONDON (Reuters) - The number of new drugs approved for sale in United States and Europe has bounced back this year, suggesting a marked slowdown in 2016 was an aberration rather than a sign of flagging research and development productivity.
 Sify1 month ago
Rediff.com

Low-cost male contraceptive finds no takers

It could ease the burden on the 225 million women in developing countries, says Ari Altstedter. IMAGE: Years of human trials on the injectable, sperm-zapping product are coming to an end, and researchers are preparing to submit it for regulatory approval. Photograph: Robert Cianflone/Getty Images Doctors are on the cusp of launching a male contraceptive. But rather than a big pharma lab, the breakthrough is emerging from a university start-up in the heart of rural India. Years of human ...
 Rediff.com2 months ago
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less